Factbox: AstraZeneca's potential coronavirus vaccine

  • 📰 Reuters
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

AstraZeneca signed its first COVID-19 vaccine supply deal with a Chinese company, Kangtai Bio, on Thursday, opening up distribution to one of the world's most populous countries.

- AstraZeneca signed its first COVID-19 vaccine supply deal with a Chinese company, Kangtai Bio, on Thursday, opening up distribution to one of the world’s most populous countries.

The company has been granted protection from future product liability claims related to the vaccine by most of the countries with which it has so far struck supply agreements, a senior executive told Reuters. *According to Italy’s health ministry, an AZD1222 shot would cost about 2.5 euros per dose in Europe.*Costs in other regions have not been disclosed.*AstraZeneca’s CEO said good data has come in so far on the shot, after early-stage clinical trials showed it was safe and produced an immune response.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

🖕🏻

Ne varsa sizde var gavurlar

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in BUSİNESS

Business Business Latest News, Business Business Headlines